Clindamycin Phosphate Injection shortage (US): status and presentations

Shortage United States · first listed 21 March 2023 · updated 8 October 2026

Dosage form	Injection
Therapy area	Anti-Infective
Presentations	4 unavailable, 2 limited, 11 available
Source	US FDA Drug Shortage Database (openFDA), checked 19 October 2026

Presentations affected

• Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) — Unavailable
• Clindamycin Phosphate, Injection, 150 mg/1 mL — Unavailable
• Clindamycin Phosphate, Injection, 600 mg/50 mL — Unavailable
• Clindamycin Phosphate, Injection, 900 mg/50 mL — Unavailable
• Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) — Available
• Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) — Available
• Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL — Available
• Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL — Available
• Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL — Available
• Clindamycin Phosphate, Injection, 300 mg/50 mL — Available
• Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial — Being discontinued
• Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus — Being discontinued
• Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial — Being discontinued
• Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus — Being discontinued
• Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial — Being discontinued
• Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus — Being discontinued

Strengths and packs as listed by the regulator. Manufacturer names and product codes are not shown.

What buyers can do

• Check whether other registered presentations or strengths can be used, and ask your wholesaler about allocation.
• For hospital and tender supply, look for manufacturers that already hold an approval in your market and can increase output.
• In a critical shortage, the FDA can allow temporary importation of a version approved in a well-regulated market. That decision is made by the FDA, case by case.
• Qualify any new source as carefully as at any other time: GMP certificate, registration status and a certificate of analysis for each batch.

See the product page for Clindamycin Phosphate Injection on PharmaTradz.

More: where licensed suppliers can step in during US shortages.

Related shortages

• Rifampin Injection
• Cefotaxime Sodium Powder, for Solution
• Rifampin Capsule
• Metronidazole Injection
• Penicillin G Benzathine Injection
• Bacitracin Ophthalmic Ointment